| Bristol-Myers Squibb SA - Reyataz 200 mg, Kapseln |
| 56288 | | 04 | | Reyataz 200 mg | | Kapseln | | J05AE08 | | Atazanavir | | 06.05.2004 | | |
|
| Composition |
| atazanavirum 200 mg ut atazanaviri sulfas, color.: E 132, excipiens pro capsula. |
| Packungsbestandteile |
| Capsules | | | | | | | | Active Agent | Dose |
|---|
| Atazanavir | 200 mg |
| | BAG: Active Agent | Dose |
|---|
| Atazanavir | 200 mg |
| | | | Inactive agents | | additional_information |
|---|
| E 132 | | color. |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
